Clinical trial
Rotavirus Efficacy and Safety Trial (REST)(V260-006)
NCT00090233 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00090233 |
|---|---|
| Title | Rotavirus Efficacy and Safety Trial (REST)(V260-006) |
| Official title | Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rotavirus Infections |
| Intervention type | Biological |
| Interventions | Rotateq™, Comparator: Placebo |
| Enrollment | 69,274 |
| Start date | Jan 1, 2001 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Aug 27, 2004 |
| Last update posted | Oct 5, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: